Clinical trial
An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome
NCT05367960 is registered in ClinicalTrials.gov with Tetra Discovery Partners as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome
- Lead sponsor
- Tetra Discovery Partners
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- November 1, 2022
- Completion date
- December 31, 2027
- Enrollment
- 314 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.